Yalamanchi Naveen 5
5 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
Yalamanchi Naveen
Director
Transactions
- Gift
Common Stock
2020-12-02−31,250→ 82,391 total(indirect: By Trust)
Footnotes (1)
- [F1]Excludes 17,530,044 shares beneficially owned by each of (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of the shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Special Purpose Fund II, LLC, which are investment funds managed by RTW, and (ii) Roderick Wong, M.D., who serves as the Managing Partner of Chief Investment Officer of RTW and who is a director of the Issuer and Chairman of the Issuer's Board of Directors, in which Dr. Yalamanchi has a pecuniary interest. Dr. Yalamanchi disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.